The Thrombophilic Pattern of Different Clinical Manifestations of Venous Thromboembolism: A Survey of 443 Cases of Venous Thromboembolism

Elisa Grifoni; Rossella Marcucci; Gabriele Ciuti; Caterina Cenci; Daniela Poli; Lucia Mannini; Agatina Alessandrello Liotta; Massimo Miniati; Rosanna Abbate; Domenico Prisco

doi:10.1055/s-0032-1301420

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2012; 38(02): 230-234
DOI: 10.1055/s-0032-1301420

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Thrombophilic Pattern of Different Clinical Manifestations of Venous Thromboembolism: A Survey of 443 Cases of Venous Thromboembolism

Elisa Grifoni

¹Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy

,

Rossella Marcucci

¹Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy

²Department of Heart and Vessels, Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

,

Gabriele Ciuti

¹Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy

,

Caterina Cenci

¹Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy

²Department of Heart and Vessels, Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

,

Daniela Poli

²Department of Heart and Vessels, Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

,

Lucia Mannini

²Department of Heart and Vessels, Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

,

Agatina Alessandrello Liotta

²Department of Heart and Vessels, Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

,

Massimo Miniati

¹Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy

,

Rosanna Abbate

¹Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy

²Department of Heart and Vessels, Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

,

Domenico Prisco

¹Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy

› Institutsangaben

Abstract

Although pulmonary embolism (PE) and deep vein thrombosis (DVT) share many risk factors, it is uncertain whether thrombophilic abnormalities may impact differently on the development of these two clinical manifestations of venous thromboembolism (VTE). To give further insight into this issue, we estimated the association of PE with different types of thrombophilia and evaluated whether these abnormalities have a different prevalence in patients presenting with PE, alone or associated with DVT, as compared with those with isolated DVT. In this study 443 consecutive patients with a first episode of VTE and 304 matched healthy controls underwent laboratory screening for thrombophilia, including natural anticoagulants, factor V Leiden and prothrombin G20210A polymorphisms, antiphospholipid antibodies, homocysteine, factor VIII, and lipoprotein(a). Of the 443 patients, 224 patients had isolated DVT, 144 had combined DVT/PE, and 75 had isolated PE. At least one thrombophilic abnormality was detected in 72.8% of DVT, 66% of DVT/EP, and 60% of isolated PE patients. A high prevalence of hyperhomocysteinemia and elevated lipoprotein(a) levels was found in all patients with no significant differences among the three groups. The prevalence of prothrombin G20210A polymorphism and of elevated factor VIII levels was significantly higher in patients with DVT and DVT/PE than in controls, but not in those with isolated PE, whereas factor V Leiden polymorphism was associated with isolated DVT but not with DVT/PE or isolated PE. In conclusion, the thrombophilic burden seems different in isolated PE versus DVT with or without PE, suggesting that PE may encompass a different pathophysiological process of thrombosis to DVT.

Keywords

venous thromboembolism - pulmonary embolism - thrombophilia

Volltext

Referenzen

References
1 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008; 34 (8) 747-761
2 Desmarais S, de Moerloose P, Reber G, Minazio P, Perrier A, Bounameaux H. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996; 347 (9012) 1374-1375
3 Manten B, Westendorp RGJ, Koster T, Reitsma PH, Rosendaal FR. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thromb Haemost 1996; 76 (4) 510-513
4 Martinelli I, Cattaneo M, Panzeri D, Mannucci PM. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost 1997; 77 (3) 440-443
5 Baglin TP, Brown K, Williamson D, Baker P, Luddington R. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population. Thromb Haemost 1997; 77 (6) 1219
6 Leroyer C, Mercier B, Escoffre M, Férec C, Mottier D. Factor V Leiden prevalence in venous thromboembolism patients. Chest 1997; 111 (6) 1603-1606
7 Turkstra F, Karemaker R, Kuijer PM, Prins MH, Büller HR. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?. Thromb Haemost 1999; 81 (3) 345-348
8 de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000; 110 (1) 125-129
9 Bounameaux H. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 2000; 356 (9225) 182-183
10 Margaglione M, Brancaccio V, De Lucia D , et al. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 2000; 118 (5) 1405-1411
11 Friedline JA, Ahmad E, Garcia D , et al. Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes. Arch Pathol Lab Med 2001; 125 (1) 105-111
12 Meyer G, Emmerich J, Helley D , et al. Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med 2001; 110 (1) 12-15
13 Martinelli I, Battaglioli T, Razzari C, Mannucci PM. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia. J Thromb Haemost 2007; 5 (1) 98-101
14 Schulman S. Thrombophilia and location of venous thromboembolism. J Thromb Haemost 2007; 5 (10) 2151-2152
15 Huisman MV, Klok FA, Karami Djurabi R, Tormene D, Simioni P, Prandoni P. Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg. J Thromb Haemost 2008; 6 (3) 544-545
16 Gadelha T, Roldán V, Lecumberri R , et al; RIETE Investigators. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry. Thromb Res 2010; 126 (4) 283-286
17 Kovac M, Mitic G, Mikovic Z , et al. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation. Clin Appl Thromb Hemost 2010; 16 (1) 66-70
18 Rossi E, Za T, Ciminello A, Leone G, De Stefano V. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia. Thromb Haemost 2008; 99 (6) 1030-1034
19 Erkekol FO, Ulu A, Numanoglu N, Akar N. High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism. Respirology 2006; 11 (1) 70-74
20 Marcucci R, Sodi A, Giambene B , et al. Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis 2007; 18 (4) 321-326
21 Miyakis S, Lockshin MD, Atsumi T , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (2) 295-306
22 Marcucci R, Liotta AA, Cellai AP , et al. Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med 2003; 115 (8) 601-605
23 Sofi F, Marcucci R, Abbate R, Gensini GF, Prisco D. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med 2007; 120 (8) 728-733
24 Lippi G, Targher G, Franchini M. Lipoprotein(a), thrombophilia and venous thrombosis. Acta Haematol 2007; 117 (4) 246-247
25 Bajzar L, Kalafatis M, Simioni P, Tracy PB. An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden. J Biol Chem 1996; 271 (38) 22949-22952
26 Parker AC, Mundada LV, Schmaier AH, Fay WP. Factor V Leiden inhibits fibrinolysis in vivo. Circulation 2004; 110 (23) 3594-3598
27 Mosnier LO, Bouma BN. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis. Arterioscler Thromb Vasc Biol 2006; 26 (11) 2445-2453